Formulation and Efficacy of Liposome-encapsulated Afatinib for Therapy of Non-small Cell Lung Cancer

Formulation and Efficacy of Liposome-encapsulated Afatinib for Therapy of Non-small Cell Lung Cancer

Background and objective Afatinib, a second-generation irreversible epidermal growth factor inhibitor receptor for the development of non-small cell lung cancer and secondary drug resistance, has low bioavailability and adverse reactions due to current oral administration. The aim of this study was...

Full description

Bibliographic Details
Main Authors: Xiaoyan LV, Junjing YIN, Xiucheng YANG, Sha LIU, Kaoxiang SUN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-09-01
Series:Chinese Journal of Lung Cancer
Subjects:
Afatinib
Liposomes
Ammonium sulfate gradient method
Ultraviolet spectrophotometry
Determination of entrapment efficiency
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2018.09.02

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2018.09.02

Similar Items